What is the treatment for bullous otitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Bullous Otitis (Bullous Myringitis)

Bullous otitis (bullous myringitis) should be treated identically to acute otitis media with systemic antibiotics targeting Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis, combined with aggressive pain management and consideration for myringotomy to drain hemorrhagic bullae in severe cases. 1

Understanding Bullous Otitis

Bullous myringitis is not a separate disease entity but rather a rare and particularly painful manifestation of acute otitis media characterized by hemorrhagic bullae on the tympanic membrane. 1 The causative organisms are identical to those in standard acute otitis media: S. pneumoniae, H. influenzae, and M. catarrhalis. 1

First-Line Antibiotic Treatment

For Children Over 3 Months of Age

  • Amoxicillin remains the first-line antibiotic at high doses (90 mg/kg/day) in communities where beta-lactamase-producing strains are infrequent. 2, 3, 4, 5

  • For children who received antibiotics in the previous 4-6 weeks or in areas with resistant organisms, use amoxicillin-clavulanate (90 mg/6.4 mg per kg per day), cefpodoxime proxetil, cefuroxime axetil, or cefdinir as initial therapy. 2

  • Treatment duration should be 8-10 days for children under 2 years and 5 days for older children. 2

For Patients with Beta-Lactam Allergies

  • Erythromycin-sulfisoxazole is an alternative for patients with beta-lactam allergies, though bacterial failure rates of 20-25% are possible. 2, 3

Critical Pain Management

Pain control is paramount in bullous myringitis as it can be excessively painful. 1

  • Prescribe analgesics based on pain severity, starting with acetaminophen or NSAIDs for mild-to-moderate pain. 2, 6

  • Pain typically improves within 48-72 hours of initiating appropriate therapy. 2, 6

Surgical Intervention for Severe Cases

Myringotomy (opening of hemorrhagic bullae) may be a medical emergency in bullous myringitis to provide immediate pain relief and prevent sensorineural hearing loss. 1 This is particularly indicated when:

  • Pain is severe and unresponsive to analgesics 1
  • There is concern for complications 1
  • Bacteriological evaluation is needed in infants under 6 months, immunocompromised patients, or treatment failures 3

Systemic Corticosteroids

Consider systemic corticosteroids in severe cases of bullous myringitis to reduce inflammation and prevent sensorineural hearing loss, which is a recognized complication. 1 However, the evidence for routine corticosteroid use in acute otitis media is limited. 2

Reassessment and Treatment Failure

  • Reassess patients within 48-72 hours if symptoms are not improving or are worsening. 2

  • Treatment failure is defined as worsening condition, persistence of symptoms beyond 48 hours, or recurrence within 4 days of treatment discontinuation. 2

  • For treatment failures, perform myringotomy with bacteriological specimen collection to guide antibiotic selection, particularly in infants under 6 months and immunocompromised patients. 2, 3

Common Pitfalls to Avoid

  • Do not confuse bullous myringitis with acute otitis externa. Bullous myringitis involves the tympanic membrane and middle ear, requiring systemic antibiotics, whereas otitis externa is treated primarily with topical therapy. 2, 6

  • Do not use topical ear drops alone for bullous myringitis, as this is a manifestation of acute otitis media requiring systemic antibiotics. 1

  • Do not delay myringotomy in severe cases, as the hemorrhagic bullae can cause significant pain and potential hearing complications. 1

  • Avoid prescribing antibiotics for isolated tympanic membrane redness without other signs of acute otitis media, as this does not warrant treatment. 2

References

Research

[Bullous myringitis demystified].

Revue medicale suisse, 2023

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Treatment of acute otitis media].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1995

Research

Treatment of otitis media.

American family physician, 1992

Research

Pharmacotherapy of otitis media.

Pharmacotherapy, 1991

Guideline

Treatment of Acute Otitis Externa

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.